Skip to main content

AlphaLISA CHO HCP Detection Kit, 5,000 Assay Points

The AlphaLISA™ immunoassay kit for CHO Host Cell Protein (HCP) Detection enables the quantitative determination of CHO HCP in buffer, cell culture media, and cell supernatants using a homogeneous AlphaLISA assay (no wash steps). The CHO HCP Detection Kit is also available in HTRF® format as an orthogonal technology.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Dynamic Range 0.52 - 3,000 ng/mL  
Limit of Detection 0.52 ng/mL  
Limit of Quantification 1.80 ng/mL  
Sample Volume 5 µL

The AlphaLISA™ immunoassay kit for CHO Host Cell Protein (HCP) Detection enables the quantitative determination of CHO HCP in buffer, cell culture media, and cell supernatants using a homogeneous AlphaLISA assay (no wash steps). The CHO HCP Detection Kit is also available in HTRF® format as an orthogonal technology.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

CHO cells are widely used expression hosts for recombinant proteins and are utilized for the generation of monoclonal antibodies. The CHO Host Cell Proteins (HCP) kit is designed to measure contaminants originating from the CHO cells used to manufacture therapeutic antibodies. This kit can be utilized to quantify CHO HCP proteins at various stages, from routine bioprocess operations to crude harvest materials to final products. Our simple procedure and robust assay offer increased throughput compared to ELISA.

Formats:

  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Features:

  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
0.52 - 3,000 ng/mL  
Limit of Detection
0.52 ng/mL  
Limit of Quantification
1.80 ng/mL  
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Blue Ice
Target
HCP
Target Class
Biologics
Technology
Alpha
Unit Size
5,000 Assay Points

Image gallery

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-5 of 5 Resources
Application Note Icon
Application Note
Advantages of using our automatable and no-wash HTRF and AlphaLISA kits for CHO HCP detection

Detecting and quantifying HCPs with automatable homogeneous immunoassays

During biotherapeutic manufacturing and production, the...

Whitepaper Icon
Whitepaper
Antibody-based therapeutic modalities in oncology

With over 200 different types of cancer, management relies on a variety of techniques such as chemotherapy, radiotherapy, and...

Whitepaper Icon
Whitepaper
Exploring the strengths, challenges, and therapeutic applications of multispecific antibodies

Unlock the future of therapeutics with multispecific antibodies

Discover the groundbreaking advancements in multispecific antibody...

Infographic Icon
Infographic
Safety rules with Revvity biotherapeutic workflows

Helping you put safety and product efficacy at the forefront of your GMP manufacturing

At Revvity we’re able to support your GMP...

Guide Icon
Guide
The issue of CHO HCPs during biopharmaceutical production

Detecting and quantifying CHO HCPs with automatable homogeneous immunoassays

In recent years recombinant therapeutic proteins and...

Scroll Icon